Skip Ribbon Commands
Skip to main content
NL FR EN
Search

 Documentatie

 Documents

 Documentation

 

​Rapporten

​

​Artikels ​​

 ​

​Officiële documenten 

Voorlopige resultaten over het gebruik en aanbod van illegale middelen tijdens de coronacrisis

 
Gender sensitieve preventie en hulpverlening
Naar gender-sensitieve preventie en hulpverlening voor vrouwelijke middelengebruikers in België 

 
Middelengebruik op muziekfestivals

 
Belgisch jaarrapport over Drugs: 
Nieuwe ontwikkelingen, trends en detail informatie
 
 
 
 

 
TDI
Rapport 2011 [FR] - [NL]
 
Rapport 2012[FR] - [NL]
 
Rapport 2013 [FR] -[NL]
 
Rapport 2014 [FR] - [NL] 

 
Rapport 2015 [FR] - [NL]​ 
 
Rapport 2016 [FR] - [NL]​​​

 
De​ indicator van behandelingsaanvragen betreffende drugs en alcohol in 2011-2014 in Brussels  [FR]​ en Wallonië 
[FR]
 

 
VAD  [NL]
 
 
 
Eurotox  [FR]
 
 
EMCDDA rapporten  [EN]
 
 
UNODC rapporten  [EN] 
 
 
 
 
 
 
WHO rapporten  [EN]

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 










 ​


​Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study​

2018 vol 76 no.17

 

 

Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage​

2018 vol.76 no.3​

 

 
Identification of a new tert-leucinate class synthetic ​cannabinoid in powder and "spice-like" herbal incenses: 5F-MDMB-PICA

Forensic Sci Int 2017 Vol. 273 p. 45-52 


 
Alternatives to prison for drug offenders in Belgium

Lisbon Addictions 24-26/10/2017, Lisbon-Portugal

 

 
Registration of treatment demands for substance use disorders in Belgium

Lisbon Addictions​ 24-26/10/2017, Lisbon-Portugal​

A case of acute intoxication due to combined use of fentanyl and U-47700

Forensic Sci Int 2016 Vol. 266 p. 68-72


Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol

Archives of pub​lic health 2016 vol.74 no.27​

 
General practice patients treated for substance use problems. A cross-national surveillance study
Lisbon Addictions 24/09/2015, Lisbon-Portugal
 
 
Non-general practice versus general practice patients treated for substance use problems
Lisbon Addictions 23/09/2015, Lisbon-Portugal

 

Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) 

Symposium Methods in Epidemiology   17/09/2015, Leuven-Belgium​

 

Hepatitis virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention
PLoS One    2014    vol.9    no.7 e103345
 
  
4-methyl-amphetamine: a health threat for recreational amphetamine users
Journal of psychopharmacology 2013    vol.27    no.9    817-822
 
 
Improved Benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10 
Archives of public health    2013 vol.71    no.
 
 

  



 


 


 


 

 

 



 

 

 

 

 

 
 ​ Een geïntegreerd drugsbeleid in België
Federale drugnota 2001  [FR] - [NL]
 
Gemeenschappelijke verklaring van de interministeriële conferentie 
Drugs 2010  [FR]​ - [NL]
 
 
Belgisch waarnemingscentrum voor drugs en drugverslaving (BMCDDA)
 
 
 
 
Europese drugsbeleid documenten 
 
 
 


































 

 

 

 

 

 

 
 

 

 

 

 

 


 

 
 
 
 

 
 

 
 

 
 

 

 

 
 
 
 
 
 

 

 



 

 

 

 

 

 
 

 
 

 

 

 

 

 

 

 

 
 


 


 


 


 


 

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​���​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

​​

​Rapports          
 Articles ​ ​ ​ Documents​​ officiels
Résultats préliminaires sur l'usage et l'offre de substances illégales pendant la crise du coronavirus

 
Un traitement et une prévention sensible au genre
Vers un traitement et une prévention sensible au genre pour femmes toxicomanes et alcooliques en Belgique 
​
Usage de drogues en milieu festif

 

 
Rapport annuel belge sur les drogues: 
 
Nouveaux développements, tendances et information détaillée 
 
 
 
 
        Chapitres séparés:

 
TDI
 
Rapport 2011 [FR] - [NL]
 
Rapport 2012 [FR] - [NL]
 
Rapport 2013 [FR] - [NL]

Rapport 2014 [FR] - [NL] 

 
Rapport 2015 [FR] - [NL]​ 

 
Rapport 2016 [FR] - [NL]​​​
 
L'indicateur de demande de traitement lié à l'usage de drogues ou d'alcool en 2011-2014 en Bruxelles [FR]​​ et Wallonie [FR]​​
 
 
VAD  [NL]
 
 
  
Eurotox  [FR]
 
 
 
Rapport de l'EMCDDA [EN] ​

 
 
Rapports de l'UNODC  [EN] 
 
   
 
 
 
 

 
Rapport de WHO  [EN]
 

 




 

 

 

 

 

 

 

 

 

 

 

 

 

Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study​

2018 vol 76 no.17​


Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage​​

2018 vol.76 no.3​​


Identification of a new tert-leucinate class synthetic cannabinoid in powder and "spice-like" herbal incenses: 5F-MDMB-PICA

Forensic Sci Int 2017 Vol. 273 p. 45-52 

Alternatives to prison for drug offenders in Belgium

Lisbon Addictions 24-26/10/2017, Lisbon-Portugal

 

 
Registration of treatment demands for substance use disorders in Belgium

Lisbon Addictions​ 24-26/10/2017, Lisbon-Portugal​

 

A case of acute intoxication due to combined use of fentanyl and U-47700

Forensic Sci Int 2016 Vol. 266 p. 68-72


Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol

Archives of pub​lic health 2016 vol.74 no.27

General practice patients treated for substance use problems. A cross-national surveillance study
Lisbon Addictions 24/09/2015, Lisbon-Portugal
 
 
Non-general practice versus general practice patients treated for substance use problems
Lisbon Addictions 23/09/2015, Lisbon-Portugal
 

Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) 

Symposium Methods in Epidemiology   17/09/2015, Leuven-Belgium​


 

Hepatitis V virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention
PLoS One    2014    vol.9    no.7 e103345
 
4-methyl-amphetamine: a health threat for recreational amphetamine users
Journal of psychopharmacology 2013  vol.27    no.9    817-822
 
Improved Benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10 
Archives of public health    2013 vol.71    no.
  

  


 


 


 




 


 


 


 


 


 


 


 


 

 

 ​
Une politique intégrée en matière de drogues pour la Belgique
Note politique du Gouvernement fédéral relative à la problématique de la drogue 2001  [FR] - [NL]
 
Déclaration conjointe de la conférence Interministérielle Drogues  2010  [FR]​ - [NL]
 
 
l'Observatoire belge des drogues et des toxicomanies  (BMCDDA)
Déclaration de mission BMCDDA  [FR-NL]
 
La transmission d'informations au BMCDDA  [FR-NL]
 
Protocole enregistrement des demandes de traitement en matière de drogues et d'alcool  [FR-NL]
 
 
Documents de politique européenne en matière de drogue 
Stratégie européen sur les drogues 2013-2020 [EN]
 
Plan d'action européen sur les drogues 2013-2016 [EN]
 

 
 

 

 

 

 

 

 

 



























 

 

 

 

 

 

 

 

 

 

 

 

 

 
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 
 
 
 
 

​

Reports   ​​
Articles ​ ​ ​ Official documents​​
Preliminay results on the use and supply of illicit substances uring the coronacrisis
Report [NL] - [FR]​

Gender sensitive prevention and treatment
Towards gender-sensitive prevention and treatment for female substance users in Belgium 

 
​
Substance use at music festivals

 

 
Belgian Annual Report o​​n Drugs: 
New developments, trends and in-depth information  

 

 

 
       Seperate chapters:

 
TDI
Report 2011 [FR] - [NL] 
 
Report 2012 [FR] - [NL]
 
Report 2013 [FR] - [NL]
 
Report 2014 [F​R] - [NL]​

 
Report 2015 [FR] - [NL]​

 
Report 2016 [FR] - [NL]​​
 
The treatment demand indicator related to drugs and alcohol in 2011-2014 in Brussels [FR]​ and Wallonia [FR]

 
 
VAD  [NL]
 
 
Eurotox  [FR]
 
 
EMCDDA reports  [EN]
 
 
UNODC reports  [EN] 
 
 
 
 
 
 
WHO reports  [EN]



 

 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
































 

 

 

 

 

 

​


 


 

 

Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study​

2018 vol 76 no.17​

 

 

Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage​

 
Archives of pub​lic health 2018 vol.76 no.3​

 

Identification of a new tert-leucinate class synthetic cannabinoid in powder and "spice-like" herbal incenses: 5F-MDMB-PICA

Forensic Sci Int 2017 Vol. 273 p. 45-52 


 
Alternatives to prison for drug offenders in Belgium

Lisbon Addictions 24-26/10/2017, Lisbon-Portugal

 

 
Registration of treatment demands for substance use disorders in Belgium

Lisbon Addictions​ 24-26/10/2017, Lisbon-Portugal

 

A case of acute intoxication due to combined use of fentanyl and U-47700

Forensic Sci Int 2016 Vol. 266 p. 68-72

 

Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol

Archives of pub​lic health 2016 vol.74 no.27


General practice patients treated for substance use problems. A cross-national surveillance study
Lisbon Addictions 24/09/2015, Lisbon-Portugal
 
 
Non-general practice versus general practice patients treated for substance use problems
Lisbon Addictions 23/09/2015, Lisbon-Portugal
 
 

Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) 

Symposium Methods in Epidemiology   17/09/2015, Leuven-Belgium​

 

Hepatitis V virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

PLoS One    2014    vol.9    no.7 e103345

 

4-methyl-amphetamine: a health threat for recreational amphetamine users

Journal of psychopharmacology 2013    vol.27    no.9    817-822

 

Improved Benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10 

Archives of public health    2013 vol.71    no.


 


 


 


 




 


 


 


 


 


 




 


 


 


 


 


 


 


 


 


 


 


 


 


 


 

 

 ​

 
An integrated drug policy in Belgium
 
Federal drugnote 2001  [FR] - [NL]
 
Joined Declaration by the Interministerial Drug Conference 2010  [FR]​ - [NL]
 
 
Belgian Monitoring Centre for Drugs and Drug Addiction (BMCDDA)
 
 
 
 
European drug policy documents